COVID-19 vaccination: Update for the ALS community

March 5, 2021 – Today the province of Ontario published details of its Phase 2 vaccination plan for COVID-19, including priority populations. People living with ALS have been identified within the highest-risk population that will be given priority. Phase 2 vaccinations are expected to take place from April to July 2021, depending on vaccine availability. More information is available on the province’s website.

February 3, 2021 – Just over a year since the first case of COVID-19 was diagnosed in Canada, vaccines have been developed and procured by the federal government. Provinces and territories are responsible for developing a vaccination strategy and delivering the vaccine to their populations. But what does this mean for families living with ALS?

The Canadian ALS Research Network (CALS), which represents the leadership of Canada’s multidisciplinary ALS clinics, has developed a guidance document to help Canadians living with ALS to be informed about the COVID-19 vaccine. If you have specific questions, your ALS neurologist is the best person to connect with.

In addition, based on the rollout strategy developed in each province, ALS Societies are assessing the need to advocate provincially for people living with ALS to be prioritized to receive the vaccine. In-home vaccination is an important consideration for people living with ALS who have mobility limitations. More information will be posted here as it is available.